Answers are grounded in this paper and cite their sources.
Experimental and field study demonstrates that Bacillus amyloliquefaciens suppresses Colletotrichum cereale and enhances yields in oats, indicating strong potential for sustainable disease control.
Oat anthracnose, primarily caused by Colletotrichum cereale , poses a significant threat to oat production in Northern China. Utilizing beneficial endophytes as biological control agents offers an eco-friendly strategy to manage this disease. Consequently, there remains a continuous need to explore novel indigenous microbial resources with reliable biocontrol potential. Bacillus amyloliquefaciens XJYM-Y9, an indigenous oat endophyte preliminarily confirmed via multilocus sequence analysis (MLSA), was evaluated for its biocontrol and plant growth promotion (PGP) potential. Dual-culture and greenhouse assays demonstrated significant antagonism against C. cereale , yielding an in vitro inhibition rate of 81.53% and an in vivo disease suppression efficacy of 80.58%. Furthermore, its cell-free supernatant (CFS) and crude lipopeptides (CLEs) induced morphological abnormalities in C. cereale mycelia. XJYM-Y9 also exhibited broad-spectrum activity against eight phytopathogens. Phenotypic assays confirmed its secretion of cell-wall-degrading enzymes (CWDEs), while PCR analysis established the genetic basis for lipopeptide biosynthesis. Following successful colonization across diverse oat tissues within 48 h, B. amyloliquefaciens XJYM-Y9 primed ISR-like defense responses in oat. Greenhouse assays supported the growth promoting potential of XJYM-Y9, as treated oat seedlings showed improvements in multiple growth parameters. In addition, field evaluations showed stable disease-control efficacy of 67.87% and a 21.59% increase in crop produce. These findings indicate that XJYM-Y9 coordinates direct antagonism, systemic colonization, and host defense activation to suppress oat anthracnose and promote growth. Its consistent field performance highlights its potential for sustainable oat disease management.
No takes yet. Share an insight, caveat, or question.
Quan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: